Post ‐treatment with Yiqifumai injection and its main ingredients attenuates lipopolysaccharide‐induced microvascular disturbance in mesentery and ileum

ConclusionThese results demonstrated the beneficial effect of post ‐treatment, which is attributable to its main ingredient Rb1 and Sch, and likely mediated by targeting TLR‐4/Src/NF‐κB signaling pathway.

Source: Microcirculation - January 23, 2021 Category: Research Authors: Ayididaer Ayan, Kai Sun, Chun ‐Shui Pan, Li Yan, Yu‐Ying Liu, Dan‐Tong Li, Jing‐Yu Fan, Jing‐Yan Han Tags: ORIGINAL ARTICLE Source Type: research